The National Healthcare Security Administration continues to carry out a special campaign to combat illegal and violations in the medical insurance drug sector.

2026-04-02 13:35:03

Abstract generation in progress

People’s Finance News, April 2—Recently, the Office of the National Healthcare Security Administration issued the “Notice on Deepening the Special Campaign to Crack Down on Illegal and Violations in the Healthcare Insurance Drug Sector” (hereinafter referred to as the “Notice”). It makes special arrangements for continuing to crack down on illegal and noncompliant issues such as the trading of reimbursable insurance “returned drugs” and other related problems. The Notice requires that starting in April 2026, using verification of clues and leads identified through drug traceability codes as the starting point, efforts to further investigate and crack down on illegal and noncompliant issues in the healthcare insurance drug sector will continue nationwide. The special campaign is divided into two phases: the first phase runs from April to July 2026, and the second phase runs from September to November 2026. The Office of the National Healthcare Security Administration will issue, at the beginning of April 2026 and at the beginning of September 2026 respectively, a batch of leads on duplicate settlement suspicions involving drug traceability codes.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.